Amplifications of RANBP9 occur in breast cancer in vivo (Additional file 3: Figure S14) and are associated with increased gene expression (Additional file 3: Figure S15), although amplifications are less common than for ERBB2, suggesting other mechanisms more typically driving its overexpression. Here, ERBB2 is linked to breast cancer.